Although there were no statistically significant differences in the comparisons due to the small number of samples, the results indicated that patients with enhanced actin α1+tumor cells had relatively low ratio of CD3+CD8+ cytotoxic T cells (Figures 7B, C). The gene discussed is CD8A; the disease is neoplasm.